Drug discovery

AI-Powered Drug Discovery: Tackling Complexity, Accelerating Breakthroughs

SandboxAQ’s AI drug discovery platform uses machine learning and physics-based simulation to predict how molecules will bind, behave, and perform as drugs before lab testing, helping teams screen millions of compounds computationally, prioritize the most promising candidates, and de-risk hard-to-drug targets faster than traditional wet-lab-first pipelines.
Explore Models

What Makes SandboxAQ an AI-First Drug Discovery Company

SandboxAQ is a science-first technology company with a dedicated biopharma team combining expertise in computational chemistry, medicinal chemistry, biology, bioinformatics, AI, and software engineering. That combination is the core answer to "what is AI drug discovery": using physics-grounded AI models, SandboxAQ uses Large Quantitative Models (LQMs) to predict how molecules will behave before they're ever synthesized in a lab, replacing slow, expensive trial-and-error with computational screening at a scale traditional drug discovery pipelines can't match.

Recent Breakthrough Research

Designed to Reduce Cost, Time, and Risk

The biggest opportunity in AI drug discovery is improving the quality of every iteration. By using AI for drug discovery to narrow the search space, teams can lower experimental load, accelerate optimization, and reduce late-stage surprises. For companies exploring AI drug discovery companies or benchmarking AI-first drug discovery companies list options, the key question is simple: which platform helps you make better bets faster? SandboxAQ is built for exactly that outcome.

Three Ways to Deploy AI in Your Drug Discovery Pipeline

SandboxAQ offers three ways to access and deploy our LQMs

Seamless LQM Integration

Plug our LQMs directly into the chat interface your team already uses every day. No rebuilding your stack, no retraining your people, just run scientific queries through your existing environment. We meet you where you are.

‍
Work With Us

Enterprise Licensing

Keep your models and data inside your walls. Train them on your proprietary chemistry, spin up specialized modules when you need them, binding prediction, generative design, whatever your R&D actually requires and scale inference at your own pace. Full ownership, zero vendor lock-in.

Frontier Partnerships

If you're building something that doesn't exist yet, let's build it together. We commit long-term funding and scientific expertise to your mission, share milestones and risk, and own a piece of what we create. This isn't outsourcing, its partnership with real skin in the game on both sides.

A Scalable Path for AI-Led Discovery

As the market for AI applications in drug discovery 2026 expands, the winners will be platforms that connect computational insight to day-to-day R&D decisions. SandboxAQ’s approach supports that shift by combining predictive modeling, simulation, and enterprise deployment into one workflow. For teams looking at AI drug discovery companies or tracking the latest drug discovery AI news, the priority should be clear: choose a system that improves hit rates, shortens cycles, and supports scalable scientific execution.

What Our Partners Are Saying

“With SandboxAQ’s platform, we increased the chemical exploration space from 250,000 molecules to 5.6 million. We identified candidate molecules faster and more efficiently with a hit rate 30 times greater.”

Dr. Stanley Prusiner,
Nobel Laureate, UCSF

“This undruggable protein target has been by far our toughest drug discovery target to date. Having enabled medicinal chemistry on multiple promising starting points is an enormous achievement and extremely exciting.”

Dr. Klaus Klumpp, Co-Founder and President of Riboscience

“SandboxAQ’s leapfrog technology could significantly impact both preclinical and clinical development of drugs, and we look forward to seeing how it could support us in delivering life-changing treatments to patients worldwide, faster”

Paul Hudson,
former CEO of Sanofi

FAQs on Ai Drug Discovery

What is an AI drug discovery platform?

An AI drug discovery platform uses machine learning and computational chemistry models to predict molecular properties such as binding affinity and mechanism of action, so research teams can prioritize candidates before costly lab synthesis and testing.
‍Read Our Published Research

How does SandboxAQ's technology differ from traditional computational chemistry tools?

SandboxAQ's Large Quantitative Models are trained on physics-grounded data and deployed via flexible access points, from LQM-enabled LLMs through Model Context Protocol to full enterprise licensing rather than being locked into a single software package, so teams can plug AI drug discovery capabilities into workflows they already use.

What are the benefits of AI for drug discovery?

AI for drug discovery can reduce time, lower development costs, improve hit rates, and help teams make more informed decisions earlier in the R&D process.

How does AI-driven drug discovery improve research efficiency?

AI-driven drug discovery helps narrow the search space, filter weak candidates faster, and focus lab efforts on molecules with stronger predicted performance.
‍Explore More In Research Paper

Where are How is SandboxAQ different from other AI drug discovery companies?AQMed's clinical studies being conducted?

SandboxAQ combines a deep computational chemistry and medicinal chemistry team with LQMs that predict function, not just binding, and offers flexible deployment via MCP integration, enterprise licensing, or co-development partnerships.
‍Read More In Our Research

What are the latest AI applications in drug discovery this year?

AI applications in drug discovery this year are expected to focus on better predictive modeling, physics-based simulation, and more scalable workflows for research teams.

Ready to Learn More?

Coming Soon

LQM's for Drug Discovery

LLM-to-LQMs integrations for drug discovery and life sciences are coming soon! Join the waitlist to be among the first to know when these and future models are available.

Join the Waitlist